	Treatment and outcomes of pulmonary mucosa-associated lymphoid tissue lymphoma: A multicenter analysis of 186 patients. Cancer Suzuki K, Miyazaki K, Asano N, Takahashi H, Koba Y, Hiramoto N, Choi I, Arima H, Uchida T, Nakamura N, Tatetsu H, Uryu H, Ito S, Kato T, Sasaki H, Murayama T, Hiraga J, Takahashi N, Kobayashi T, Takao M, Tawara I, Yamaguchi M. PMID: 41954337 [PubMed - indexed for MEDLINE]
	Frailty as a Key Clinical Indicator in Older Patients with Advanced Lung Cancer: A Systematic Review and Meta-Analysis of Prevalence, Risk Factors, and Clinical Implications. J Palliat Med Liu H, Chen Y, Wang S. PMID: 41954010 [PubMed - as supplied by publisher]
	Ready, Set, Screen: Evaluating Community Readiness for Lung Cancer Screening Among Non-Hispanic Black Populations in Florida: Brief Report. JTO Clin Res Rep Monestime S, White A, Theodore R, Raez LE, Granville CA, Harris D, King JC. PMID: 41953891 [PubMed]
	Case report: Double-lung transplantation for Hermansky-Pudlak syndrome-associated pulmonary fibrosis and early-stage lung cancer. Front Immunol Li X, Ding L, Li B, Ding Z, Wang K, Li J, Gao X. PMID: 41953037 [PubMed - indexed for MEDLINE]
	Decoding Brain Metastasis With Liquid Biopsy: Biomarkers and Technologies in EGFR-Mutant NSCLC. Cancer Med Sun Y, Wang Q, Zhu P, Li Z, Liu T, Yin R. PMID: 41952341 [PubMed - indexed for MEDLINE]
	The Promise of Chemotherapy-Free Strategies in Advanced Driver-Negative NSCLC: A Systematic Review and Network Meta-Analysis of Antiangiogenic Combination Therapies. Cancer Med Li Z, Zhao W, Guo W, Lu X, Jia C, Ma J, Zhou Q, Yang X, Jiang J. PMID: 41952287 [PubMed - indexed for MEDLINE]
	Survival by Detection Pathway in Patients With Lung Cancer-A Nationwide Descriptive Epidemiological Study in Japan. Int J Cancer Koto R, Yamamoto A, Takashima I, Iwao C, Shin JH, Hayashi Y, Kitagawa H, Horie Y. PMID: 41952286 [PubMed - as supplied by publisher]
	Predicting lung cancer stage at diagnosis based on self-reported symptoms and background factors using machine learning models. Sci Rep Gustavell T, Sissala N, Pernemalm M, Baba, Eriksson LE. PMID: 41951730 [PubMed - as supplied by publisher]
	Corrigendum to "Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial": [Ann Oncol 36 (2025) 775-785]. Ann Oncol Felip E, Rojas CI, Schenker M, Kowalski DM, Casarini IA, Csöszi T, , Martins J, Calles Blanco A, Wang CC, Wang M, Ramirez Fallas RAL, Yoshioka H, Nair S, Song X, Deng X, Lala M, Eiras R, Takahashi T. PMID: 41951457 [PubMed - as supplied by publisher]
	Landscape of volatile organic compounds for differential diagnosis, pathological typing, and severity prediction in lung cancer: a large population-based prospective study. J Adv Res Xiang R, Hu P, Liu M, Dai W, Tian B, Li W, Liu X, Zhuang X, Yang X, Xie T, Hu B, He J, Ma K, Bie J, Shi Y, Liao J, Xie S, Yang X, Li J, Yang Y, Liao P, Xie T, Zhang Q, Luo H, Duan Y, Li Q. PMID: 41951045 [PubMed - as supplied by publisher]
	SKYSCRAPER-02C: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer in China. J Thorac Oncol Lu S, Fang J, Yu Y, Fan Y, Dong X, Wang Z, Wang Q, Wang J, Cui J, Pan H, Wu Q, Lin C, Zhang L, Meng R, Liu C, Huang X, Patil NS. PMID: 41950998 [PubMed - as supplied by publisher]
	Less Is More, But Me-Too Should Not Be the Strategy for Lung Cancer Treatment in 2026. Am Soc Clin Oncol Educ Book Bortolot M, Saw SPL, Pietroluongo E, Rajath G, Patel A, Garassino M, Remon J. PMID: 41950438 [PubMed - indexed for MEDLINE]
	Multimodal Assessment of Biological Age Following Radiation Therapy Among Patients With Early-Stage NSCLC. JAMA Netw Open Lee G, Haugg F, Bontempi D, He J, Bitterman DS, Pai S, Guthier C, Fitzgerald KJ, Kozono DE, Kann BH, Aerts HJWL, Mak RH. PMID: 41949867 [PubMed - indexed for MEDLINE]
	Cost-effectiveness of pembrolizumab plus chemotherapy for metastatic non-small cell lung cancer: a head-to-head trial vs. real-world comparison. J Med Econ Teppala S, Koo J, Clarke S, Lu CY. PMID: 41949826 [PubMed - indexed for MEDLINE]
	Incidental discovery of second primary lung tumors in breast cancer patients: An institutional case series. Oncologist Iancu A, Gwin W, Vinayak S, Linden H, Specht J, Symonds L, Davidson N, Hunter N. PMID: 41949764 [PubMed - as supplied by publisher]
	Applications and challenges of multi-omics approaches in lung cancer research and precision treatment. Front Genet Zhang S, Xu R, Zheng Q, Chen B, Li W. PMID: 41948518 [PubMed]
	CLIC6 and ANLN: novel exosome-related prognostic markers and therapeutic targets in lung adenocarcinoma. Front Immunol Miao Y, Li T, Li R, Liu Y. PMID: 41948338 [PubMed - indexed for MEDLINE]
	Radon and Non-Cancer Pulmonary Health Effects in Children: A State of The Art Review. Pediatr Pulmonol Banzon TM, Koutrakis P, Garshick E, Gaffin JM, Phipatanakul W. PMID: 41947778 [PubMed - indexed for MEDLINE]
	Impact of Rural Hospital Closures on Survival Among Medicare Beneficiaries Diagnosed With Colorectal, Lung, Breast, and Prostate Cancer. J Rural Health Liu Z, Gao D, Martin T, Winegar R, Giordano SH, Kuo YF. PMID: 41947577 [PubMed - indexed for MEDLINE]
	Protocol for the development and validation of a risk score to predict risk of adverse events associated with systemic anti-cancer treatment in late-stage lung cancer: Lung Cancer Improved Decisions (LUCID). Diagn Progn Res Almossawi O, Steventon L, Keogh R, Diaz-Ordaz K, Wang Z, Challenger A, Dodwell D, Forster M, Man KKC, Wei L, Masento S, Januszewski A, Chambers P. PMID: 41947265 [PubMed]

Articles 1 - 20 / 157794

Page 1 of 7890



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy